Biotène Fluoride Toothpaste

Biotène was originally developed to provide relief for xerostomia, commonly known as dry mouth. The brand was first innovated and launched by Laclede, Inc., a California-based laboratory specializing in enzyme-based oral care products. Its formula was unique for its time, focusing on non-irritating ingredients and avoiding harsh foaming agents like sodium lauryl sulfate (SLS), which can exacerbate oral dryness.

Over the decades, the brand's success led to its acquisition by larger pharmaceutical and consumer healthcare entities. It eventually became a core part of the GlaxoSmithKline (GSK) consumer healthcare portfolio. In 2022, following a significant corporate demerger of GSK's consumer division, the brand became a flagship product of the newly formed independent company, Haleon. Today, Biotène is recognized globally as a leader in specialized oral care for dry mouth management and is widely recommended by dental professionals.

While the brand maintains a global manufacturing footprint to serve international markets, a significant portion of its production for the North American market remains based in the United States. As part of the Haleon family, Biotène continues to benefit from extensive research and development in consumer health, maintaining its position as a specialized solution for patients with sensitive oral conditions.